StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Quoin Pharmaceuticals

Quoin Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Quoin Pharmaceuticals figures

See a number that looks wrong?